Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Nucleolus02:55

The Nucleolus

10.0K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

10.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression.

Experimental & molecular medicine·2026
Same author

Joint effects of visual acuity impairment and visual field loss on reading performance: a low-vision simulation in Chinese readers.

Eye and vision (London, England)·2026
Same author

Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.

International journal of pharmaceutics: X·2026
Same author

A grasp point generation algorithm for waste handling based on a generative reasoning network.

PloS one·2026
Same author

Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancer.

Cancer letters·2026
Same author

A combined Monte Carlo and experimental approach to correct foci overlap in quantifying carbon-ion-induced DNA double-strand breaks.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same journal

Emerging artificial intelligence advances in oncology: latest updates from the 2026 AACR annual meeting.

Journal of hematology & oncology·2026
Same journal

Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment.

Journal of hematology & oncology·2026
Same journal

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

Journal of hematology & oncology·2026
Same journal

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Journal of hematology & oncology·2026
Same journal

Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen density.

Journal of hematology & oncology·2026
Same journal

Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer.

Journal of hematology & oncology·2026
See all related articles

Related Experiment Video

Updated: Dec 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K

RNA-binding proteins in tumor progression.

Hai Qin1, Haiwei Ni1, Yichen Liu1

  • 1School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 639 Longmian Road, Nanjing, 211198, People's Republic of China.

Journal of Hematology & Oncology
|July 13, 2020
PubMed
Summary
This summary is machine-generated.

RNA-binding proteins (RBPs) regulate RNA processing and transport, impacting gene expression. Dysregulation of these proteins is linked to tumor development, highlighting their role in cancer progression.

Keywords:
PolyadenylationRNA splicingRNA-binding proteinsmRNA localization carcinomamRNA stability

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.4K

Related Experiment Videos

Last Updated: Dec 15, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.4K

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • RNA-binding proteins (RBPs) are crucial for dynamic spatiotemporal regulation of RNA.
  • They control RNA processing and transport, including splicing, polyadenylation, mRNA stability, localization, and translation.
  • Aberrant RNA processing contributes to abnormal protein phenotypes and tumor development.

Purpose of the Study:

  • To summarize RBPs involved in tumor progression.
  • To elucidate the molecular mechanisms underlying RBP regulation and function in cancer.
  • To advance the understanding of post-transcriptional gene regulation in tumorigenesis.

Main Methods:

  • Literature review and analysis of existing studies on RBPs in cancer.
  • Summarization of molecular mechanisms of RBP regulation.
  • Compilation of data on RBP involvement in tumor progression.

Main Results:

  • Identified key RBPs implicated in various stages of tumor progression.
  • Detailed the specific post-transcriptional regulatory roles of these RBPs.
  • Highlighted the link between altered RBP function and cancer development.

Conclusions:

  • RBPs play a significant role in cancer progression through post-transcriptional gene regulation.
  • Understanding RBP mechanisms offers potential therapeutic targets for cancer treatment.
  • This review provides a comprehensive characterization of post-transcriptional gene regulation in tumors.